Phase II trial of chemotherapy plus bevacizumab as second-line therapy for patients with metastatic colorectal cancer that progressed on bevacizumab with …

S Tsutsumi, K Ishibashi, N Uchida, H Ojima… - Oncology, 2012 - karger.com
Objectives: BRiTE and ARIES (observational cohort studies) provided valuable information
on continued use of bevacizumab (BV) beyond progression (BBP). This trial evaluates the …
被引用次数：13 相关文章

Phase II trial of chemotherapy plus bevacizumab as second-line therapy for patients with metastatic colorectal cancer that progressed on bevacizumab with …

S Tsutsumi, K Ishibashi, N Uchida, H Ojima… - …, 2012 - pubmed.ncbi.nlm.nih.gov
Objectives BRiTE and ARIES (observational cohort studies) provided valuable information
on continued use of bevacizumab (BV) beyond progression (BBP). This trial evaluates the …

Phase II trial of chemotherapy plus bevacizumab as second-line therapy for patients with metastatic colorectal cancer that progressed on bevacizumab with …

S Tsutsumi, K Ishibashi, N Uchida, H Ojima… - Oncology, 2012 - europepmc.org
Objectives BRiTE and ARIES (observational cohort studies) provided valuable information
on continued use of bevacizumab (BV) beyond progression (BBP). This trial evaluates the …

[引用][C] Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with Metastatic Colorectal Cancer That Progressed on Bevacizumab …

S Tsutsumi, K Ishibashi, N Uchida, H Ojima… - Oncology, 2012 - cir.nii.ac.jp
Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with
Metastatic Colorectal Cancer That Progressed on Bevacizumab with Chemotherapy: The …

Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with Metastatic Colorectal Cancer That Progressed on Bevacizumab with …

S Tsutsumi, K Ishibashi, N Uchida, H Ojima… - …, 2012 - search.ebscohost.com
Objectives: BRiTE and ARIES (observational cohort studies) provided valuable information
on continued use of bevacizumab (BV) beyond progression (BBP). This trial evaluates the …

Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with Metastatic Colorectal Cancer That Progressed on Bevacizumab with …

S Tsutsumi, K Ishibashi, N Uchida, H Ojima… - …, 2012 - search.proquest.com
BRiTE and ARIES (observational cohort studies) provided valuable information on
continued use of bevacizumab (BV) beyond progression (BBP). This trial evaluates the …

[引用][C] Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with Metastatic Colorectal Cancer That Progressed on Bevacizumab …

S TSUTSUMI, K ISHIBASHI, H KUWANO… - …, 2012 - pascal-francis.inist.fr
Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with
Metastatic Colorectal Cancer That Progressed on Bevacizumab with Chemotherapy: The Gunma …

Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with Metastatic Colorectal Cancer That Progressed on Bevacizumab with …

S Tsutsumi, K Ishibashi, N Uchida, H Ojima… - Oncology, 2012 - karger.com
Objectives: BRiTE and ARIES (observational cohort studies) provided valuable information
on continued use of bevacizumab (BV) beyond progression (BBP). This trial evaluates the …

[引用][C] Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with Metastatic Colorectal Cancer That Progressed on Bevacizumab …

S TSUTSUMI, K ISHIBASHI, N UCHIDA, H OJIMA… - Oncology, 2012 - Karger